Featured Research

from universities, journals, and other organizations

Risk of heart attack, stroke among diabetes patients significantly lower after gastric bypass

Date:
November 13, 2013
Source:
American Society for Metabolic & Bariatric Surgery (ASMBS)
Summary:
New research shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

The five-year risk of death from cardiovascular disease dropped by 18 percent and the risk of developing moderate to severe kidney disease dropped by 45 percent. Patients were also at significantly less risk for intermittent claudication, pain caused by poor circulation, (four-year risk reduction of 47%) and other complications including diabetic retinopathy.

The research was presented at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery (ASMBS) during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society (TOS).

"This study emphasizes that gastric bypass dramatically changes the trajectory of many chronic diseases associated with diabetes and improves multiple cardiovascular risk factors in the long term," said study co-author Stacy A. Brethauer, MD, Staff Physician in the Section of Laparoscopic and Bariatric Surgery at Cleveland Clinic.

The study followed 131 patients with diabetes and obesity for a period of about six years after gastric bypass surgery. On average, patients lost 60 percent of their excess weight and had a diabetes remission rate of 61 percent. The average patient in the study had type 2 diabetes for more than six years before surgery.

Using multiple validated risk assessment models including the Framingham Risk Score, researchers were able to determine a patient's relative risk for coronary heart disease, stroke, myocardial infarction (heart attack), peripheral vascular disease (PVD), cardiovascular mortality and diabetic retinopathy. In all cases, surgery patients saw double digit decreases in the relative risk of developing these individual complications linked to diabetes. The overall risk of developing coronary heart disease, stroke or peripheral vascular disease within the next 10 years dropped by 27 percent.


Story Source:

The above story is based on materials provided by American Society for Metabolic & Bariatric Surgery (ASMBS). Note: Materials may be edited for content and length.


Cite This Page:

American Society for Metabolic & Bariatric Surgery (ASMBS). "Risk of heart attack, stroke among diabetes patients significantly lower after gastric bypass." ScienceDaily. ScienceDaily, 13 November 2013. <www.sciencedaily.com/releases/2013/11/131113080018.htm>.
American Society for Metabolic & Bariatric Surgery (ASMBS). (2013, November 13). Risk of heart attack, stroke among diabetes patients significantly lower after gastric bypass. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2013/11/131113080018.htm
American Society for Metabolic & Bariatric Surgery (ASMBS). "Risk of heart attack, stroke among diabetes patients significantly lower after gastric bypass." ScienceDaily. www.sciencedaily.com/releases/2013/11/131113080018.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins